In a welcome move, McKesson saw its Relative Strength Rating rise from 66 to 75 on Thursday.
This proprietary rating measures market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research reveals that the best stocks often have an RS Rating of above 80 in the early stages of their moves. See if McKesson can continue to rebound and hit that benchmark.
Can You Really Time The Stock Market?
While the stock is not near an ideal buy point right now, see if it is able to form and break out of a proper base.
Top and bottom line growth moved higher last quarter. Earnings were up 13%, compared to 8% in the prior report. Revenue increased from 6% to 21%.
The company earns the No. 2 rank among its peers in the Medical-Wholesale Drugs industry group. is the top-ranked stock within the group.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
